Elena Mihailovna Manoshkina

Elena Mihailovna Manoshkina

Auto-generated profile, based on publicly available information

Elena Mihailovna Manoshkina

Russian Research Institute of Health

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
VSV.S. Stupak
V.S. Stupak
AZA.V. Zubko
A.V. Zubko
EME.M. Manoshkina
E.M. Manoshkina
ОКОльга Сергеевна Кобякова
Ольга Сергеевна Кобякова
IDI.A. Deev
I.A. Deev
EEE.N. Enina
E.N. Enina
Пандемия новой коронавирусной инфекции SARS-CoV-2 (COVID-19) вызвала беспрецедентную нагрузку на системы здравоохранения во всем мире. Российская Федерация продемонстрировала высокий уровень готовности к борьбе с пандемией COVID-19. Прежде всего, это выразилось в оперативном перераспределении ресурсных мощностей в сторону эффективного оказания медицинской помощи пациентам с COVID-19. С этой целью для данного контингента специально созданы временные госпитали, а также перепрофилирован имеющийся коечный фонд. Разработаны и утверждены схемы маршрутизации пациентов с острыми респираторными вирусными инфекциями (ОРВИ) и внебольничной пневмонией. Утверждены временные правила учета информации и ведения информационного ресурса учета информации в целях предотвращения распространения COVID-19 с использованием единой государственной информационной системы в сфере здравоохранения. С декабря 2020 г. в нашей стране начата масштабная, а с января 2021 г. — массовая вакцинация взрослого населения против COVID-19. Мобилизация кадровых ресурсов страны для борьбы с пандемией, своевременное доведение до врачей актуальных клинических рекомендаций о лечении пациентов позволили эффективно ответить на вызовы пандемии COVID-19. Возвращение системы здравоохранения в обычный режим деятельности является первоочередной задачей на современном этапе.

1 January 2019 in Social Aspects of Population Health
Verified
Journal Article
Closed access
MBM.N. Banteva
M.N. Banteva
EME.M. Manoshkina
E.M. Manoshkina
TST.A. Sokolovskaya
T.A. Sokolovskaya
EME.N. Matveev
E.N. Matveev

7 September 2022 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
BAB. G. Alekyan
B. G. Alekyan
SBSergey Boytsov
Sergey Boytsov
ВГВладимир Ганюков
Владимир Ганюков
EME. M. Manoshkina
E. M. Manoshkina
Aim. To compare and analyze the results of myocardial revascularization in the Russian Federation (RF) with acute coronary syndrome (ACS) before the onset (2018-2019) and during the novel coronavirus infection (COVID-19) pandemic (2020-2021).Material and methods. The analysis included the number of cases of ST-segment elevation myocardial infarction (STEMI), non-ST-segment elevation acute coronary syndrome (NSTE-ACS), the number of cases of myocardial revascularization in the above forms of ACS, the number of deaths depending on the form of ACS and the method performed revascularization. The period of time before the start of the coronavirus pandemic corresponded to the annual data received in the Russian Federation for 2018-2019. The period of the coronavirus disease pandemic corresponded to the annual data received in the country for 2020-2021. Absolute, relative, estimated values of patient hospitalization, myocardial revascularization procedures, and mortality in ACS were compared between time periods before and during the COVID-19 pandemic. The data for analysis were obtained from the monitoring of the Ministry of Health of Russia.Results. In 2018 and 2019 in the RF, 531,019 and 501,238 patients were hospitalized with a diagnosis of ACS, and during the pandemic (2020-2021) - 403,931 and 397,930 patients, respectively. Reduction in the number of patients diagnosed with ACS admitted to hospitals in Russia by 22.32% in 2020-2021 years was mainly due to a significant decrease in hospitalizations of patients with a diagnosis of NSTE-ACS (by 29.03%). At the same time, admission to clinics of patients with STEMI decreased only by 6.02%. During the COVID-19 pandemic, mortality increased significantly in PPCI (by 9.6%) and in the general STEMI group (by 12.3%); significantly increased mortality both in the general group (by 48%) and during PCI in patients with NSTE-ACS (by 28.6%); there was an increase in the average annual number of PPCI (by 12.6%), which was accompanied by an increased average annual number of PPCI per 1 million of population (up to 451 per 1 million of population); a slight increase in the average time "symptom-balloon" (by 2 minutes) was recorded; there was an absolute slight decrease and a relative increase in the number of PCIs in NSTE-ACS (by 2.7% and 37.1%, respectively). In 2021, in the Russian Federation, primary PCI was performed in 50.2%, thrombolytic therapy - in 23.1%, and 26.7% of patients remained without reperfusion. Pharmacoinphasive strategy was applied in 60%, and isolated thrombolysis - in 40% of patients.Conclusion. During the COVID-19 pandemic, revascularization in patients with ACS in Russia corresponded to the following trends recorded in the literature: increased hospital mortality in PPCI and in the general STEMI group; hospital mortality both in the general group and during PCI in patients with NSTE-ACS. The indicators of myocardial revascularization in ACS in the RF during the pandemic were fundamentally different from the data of Western countries: there was an increase in the average annual number of PPCI and the average annual number of PPCI per 1 million population; a slight increase in the average symptom-balloon time was recorded; revealed an absolute slight decrease and a relative increase in the number of PCIs in NSTE-ACS.

15 December 2021 in Annals of the Russian academy of medical sciences
Verified
Journal Article
Closed access
PDF file
VSVladimir I. Starodubov
Vladimir I. Starodubov
VSValerij S. Stupak
Valerij S. Stupak
EMElena M. Manoshkina
Elena M. Manoshkina
ISIrina M. Son
Irina M. Son
Background. Taking into account the special medical and social significance of oncological diseases, as well as taking into account that patients suffering from neoplasms are a special risk group for developing complications of coronavirus infection, it seems relevant to study the impact of the COVID-19 pandemic on the level of morbidity and hospital lethality of patients with neoplasms. Aims to study the trends of morbidity and hospital lethality due to neoplasms in the Russian Federation before and during the pandemic of the new coronavirus infection COVID-19. Methods. The indicators of primary and general morbidity, hospital lethality from neoplasms of the adult population were calculated on the basis of federal statistical observation data contained in reporting forms No. 12 and No. 14 of all subjects of the Russian Federation for 20152020. Results. During the period from 2015 to 2019, an increase in the general (by 14.8%) and primary (by 4.8%) incidence of neoplasms was noted in the Russian Federation. In 2020, compared with 2019, on the contrary, the indicators of general (by 5.0%) and primary (by 17.4%) incidence of neoplasms decreased. Hospital lethality due to neoplasms also increased during 20152019, in total it increased by 19.2%, in one year (2020) hospital lethality increased by 6.6%. A similar situation has developed in all federal districts and most regions of the country. Conclusions. The decline in the incidence of neoplasms in 2020, with their previous continuous growth, reflects the difficult situation that has developed during the pandemic of a new coronavirus infection in the healthcare of the Russian Federation. The increase in hospital lethality from neoplasms indicates a more severe course of coronavirus infection in adult patients with malignant neoplasms and a more frequent development of fatal complications in them.

1 January 2021 in Russian Journal of Preventive Medicine
Verified
Journal Article
Closed access
ISI.M. Son
I.M. Son
VSV.I. Starodubov
V.I. Starodubov
EME.M. Manoshkina
E.M. Manoshkina
VSV.S. Stupak
V.S. Stupak
С учетом особой значимости болезней системы кровообращения (БСК) в формировании основных показателей состояния здоровья населения представляет научный и практический интерес изучение тенденций заболеваемости БСК взрослого населения и динамики, связанной с ними больничной летальности до и во время пандемии COVID-19. ЦЕЛЬ ИССЛЕДОВАНИЯ Изучить тенденции показателей заболеваемости БСК и связанной с ними больничной летальности взрослого населения в Российской Федерации на фоне новой коронавирусной инфекции (COVID-19). МАТЕРИАЛ И МЕТОДЫ Показатели первичной и общей заболеваемости БСК, а также связанной с ними больничной летальности взрослого населения, рассчитаны на основании годовых форм федерального статистического наблюдения №12 и №14 за 2015—2020 гг. РЕЗУЛЬТАТЫ В течение периода с 2015 по 2019 г. в Российской Федерации отмечался рост как общей заболеваемости БСК (на 12,9%), так и первичной заболеваемости (на 14,6%). В 2020 г. по сравнению с 2019 г. была отмечена убыль показателя общей заболеваемости БСК (на 6,5%) и первичной заболеваемости (на 15,9%). Динамика показателя больничной летальности вследствие БСК за период с 2015 по 2019 г. характеризовалась незначительным ростом (на 7,3%); на фоне пандемии COVID-19 в 2020 г. по сравнению с 2019 г. рост этого показателя составил 58,9%. ЗАКЛЮЧЕНИЕ Убыль показателей заболеваемости БСК с одновременным значительным ростом и связанной с ними больничной летальности в 2020 г. отражает напряженную ситуацию, сложившуюся в системе здравоохранения Российской Федерации во время пандемии COVID-19, а также свидетельствует об утяжелении течения острых и хронических форм БСК.

15 May 2020 in Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)
Verified
Journal Article
Open access
PDF file
МБМ. Н. Бантьева
М. Н. Бантьева
ЕMЕ. M. Manoshkina
Е. M. Manoshkina
EME. N. Matveev
E. N. Matveev
In recent decades, the Russian Federation has seen an increase in the incidence of the population, including children and adolescents.Objective: to identify trends in the incidence and “to chronize” the pathology of young men in the Russian Federation. Using the method of descriptive statistics, the authors analyzed the overall and for the first time recorded incidence in 15–17-year-old men in 2000–2017. The authors noted a 35,8% increase in the overall incidence rate and a 35,4% increase in the for the first time recorded incidence rate. The maximum increase in the overall incidence is observed in the following classes: neoplasms (2,6 times), blood and bloodforming organs diseases (2 times), congenital anomalies (malformations; 1,8 times), circulatory system diseases (1,7 times), the musculoskeletal system and connective tissue diseases (1,6 times), endocrine and metabolic disorders (1,5 times). Based on theoverall and for the first time registered incidence the authors calculated the “chronicity” of diseases. With a general growth rate of this indicator of 0,3% there is a significant growth of this indicator for certain diseases: mental disorders and behavioral disorders (2,1 times), congenital anomalies (malformations; 1,9 times), endocrine system diseases, metabolic disorders (1,5 times).